AWM Investment Company Inc. Cuts Position in InfuSystem Holdings, Inc. $INFU

AWM Investment Company Inc. decreased its holdings in shares of InfuSystem Holdings, Inc. (NYSE:INFU) by 21.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,272,296 shares of the company’s stock after selling 353,984 shares during the quarter. AWM Investment Company Inc. owned about 6.23% of InfuSystem worth $7,939,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Jane Street Group LLC raised its position in InfuSystem by 943.1% in the second quarter. Jane Street Group LLC now owns 186,159 shares of the company’s stock valued at $1,162,000 after purchasing an additional 168,312 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of InfuSystem in the second quarter valued at about $33,000. Qube Research & Technologies Ltd purchased a new stake in shares of InfuSystem during the 2nd quarter valued at about $234,000. WINTON GROUP Ltd raised its holdings in shares of InfuSystem by 150.2% during the 2nd quarter. WINTON GROUP Ltd now owns 65,121 shares of the company’s stock valued at $406,000 after buying an additional 39,090 shares during the period. Finally, Jump Financial LLC lifted its position in InfuSystem by 146.0% during the 2nd quarter. Jump Financial LLC now owns 26,355 shares of the company’s stock worth $164,000 after acquiring an additional 15,640 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Stock Up 0.3%

Shares of NYSE:INFU opened at $9.24 on Friday. The firm has a market cap of $187.90 million, a PE ratio of 154.03 and a beta of 1.71. The company has a fifty day simple moving average of $9.62 and a 200 day simple moving average of $8.41. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a 12-month low of $4.61 and a 12-month high of $11.04.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Zacks Research downgraded shares of InfuSystem from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Roth Capital restated a “buy” rating and issued a $14.00 target price (up from $13.00) on shares of InfuSystem in a research note on Tuesday, November 4th. Finally, Lake Street Capital started coverage on shares of InfuSystem in a research note on Monday, September 22nd. They set a “buy” rating and a $15.00 price target on the stock. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, InfuSystem presently has a consensus rating of “Buy” and an average price target of $14.50.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.